Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Amortizatization of Intangibles (2017 - 2025)

Lisata Therapeutics (LSTA) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $14000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles fell 84.62% year-over-year to $14000.0, compared with a TTM value of $154000.0 through Sep 2025, down 75.44%, and an annual FY2024 reading of $455000.0, down 52.6% over the prior year.
  • Amortizatization of Intangibles was $14000.0 for Q3 2025 at Lisata Therapeutics, down from $20000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $283000.0 in Q3 2023 and bottomed at $14000.0 in Q3 2025.
  • Average Amortizatization of Intangibles over 3 years is $135454.5, with a median of $133000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles fell 8.98% in 2024, then crashed 84.96% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $251000.0 in 2023, then plummeted by 68.53% to $79000.0 in 2024, then crashed by 82.28% to $14000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for LSTA at $14000.0 in Q3 2025, $20000.0 in Q2 2025, and $41000.0 in Q1 2025.